New Tool: ProSource
Check out our packaging and processing solutions finder, ProSource.

Betaxolol Recalled Due to Packaging Mix-Up

One lot of Betaxolol was recalled due to the discovery of a rogue oxycodone tablet in a bottle.

Screen Shot 2022 04 18 At 2 42 14 Pm
Getty Images

A recent Forbes article discussed a situation where an oxycodone tablet made its way into a bottle of blood pressure medication, spurring a recall. KVK Tech issued the recall of a specific lot of their betaxolol tablets due to the discovery of a single 5 mg oxycodone HCl tablet. The mix-up could have potential serious consequences, as these medications are obviously not interchangeable. Betaxolol is a beta blocker that lowers blood pressure by dilating blood vessels and slowing heart rate, while oxycodone is a controlled substance typically prescribed for pain relief, but it can also cause sedation, euphoria, and respiratory depression. 

The rogue oxycodone tablet, which closely resembles betaxolol tablets in appearance, may lead to accidental ingestion of  oxycodone, which is particularly dangerous for those with weaker heart and lung function or a history of opioid abuse. Though it’s unclear exactly how the oxycodone tablet ended up among the betaxolol tablets, individuals are urged to return affected product for a refund. 

How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More
How to Honor a Leader
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub